Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 710-716

  Golenia, Brandy S ^a   Levine, Alexander R ^a   Moawad, Iman M ^a   Yeh, D Dante ^a   Arpino, Paul A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antibiotics; Dosing nomogram; ICU; Vancomycin

Indexed keywords

CREATININE; HYPERTENSIVE FACTOR; VANCOMYCIN;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY FUNCTION; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NOMOGRAM; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY;

ANTIBIOTICS; DOSING NOMOGRAM; ICU; VANCOMYCIN;

ANTI-BACTERIAL AGENTS; BODY WEIGHT; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NOMOGRAMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84883552057     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.01.004     Document Type: Article

References (19)

1. Vincent J.L., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302(21):2323-2329.
2. Ho K.M., Robinson J.O. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 2009, 37(3):457-463.
3. Dupont H., et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001, 27(2):355-362.
4. Iregui M., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122(1):262-268.
5. Rybak M., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009, 66(1):82-98.
6. Liu C., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52(3):285-292.
7. Yeh D.D., Lunghi K.M. Traditional weight-based vancomycin dosing is inadequate in critically ill trauma patients. Eur J Trauma Emerg Surg 2012, 38(3):301-306.
8. Aubron C., et al. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients. Ann Pharmacother 2011, 45(10):1193-1198.
9. Kullar R., et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy 2011, 31(5):441-448.
10. Thalakada R., et al. Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 canadian teaching hospitals. Can J Hosp Pharm 2012, 65(3):180-187.
11. Michalets E.L., et al. Outcomes associated with AUC24/MIC nomogram dosing of vancomycin. Ann Pharmacother 2011, 45(5):687-689.
12. Stevens L.A., et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354(23):2473-2483.
13. Stevens L.A., et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009, 54(1):33-42.
14. Nyman H.A., et al. Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011, 31(11):1130-1144.
15. Hazlewood K.A., et al. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?. Am J Med 2010, 123(2):182e1-182e7.
16. Lodise T.P., et al. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009, 49(4):507-514.
17. Farber B.F., Moellering R.C. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983, 23(1):138-141.
18. Devlin J.W., Barletta J.F. Principles of drug dosing in critically ill patients. Critical Care Medicine: Principles of diagnosis and management in the adult 2008, 33. Elsevier, Philadelphia, PA. 3rd ed. J.E. Parillo, J.E. Dellinger (Eds.).
19. Jeffres M.N., et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 2006, 130(4):947-955.